GCVI Summit 2018
Skip Content

13 September 2017

DNA Script reveals series A story

Merck Group and Illumina were among the investors in a $13.2m round, along with Idinvest Partners, Kurma Partners and existing backer Sofinnova Partners.

Author: Callum Cyrus, Reporter

France-based life sciences startup DNA Script secured €11m ($13.2m) yesterday in a series A round featuring corporate venturing subsidiaries of pharmaceutical firm Merck Group and genetics technology producer Illumina.